• Most Popular
  • Most Shared

Forest says once-daily Alzheimer's drug effective

Tue Feb 5, 2008 8:19am EST

Stocks

   

BOSTON, Feb 5 (Reuters) - Forest Laboratories Inc (FRX.N) said on Tuesday that patients in a late-stage clinical trial who took a once-daily formulation of its Alzheimer's drug Namenda had a significant improvement in symptoms compared with those who took a placebo.

Stocks

The company, which already sells a twice-daily formulation of the drug, evaluated the efficacy and safety of an extended release version of the drug in patients with moderate to severe Alzheimer's disease currently treated with a drug in the class known as cholinesterase inhibitors.

The company said that based on the results, which showed marked improvement in certain tests of mental function, it will pursue a marketing application for the drug. (Reporting by Toni Clarke, editing by Gerald E. McCormick)

Stocks


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets